Sign Up to like & get
recommendations!
3
Published in 2022 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-022-06456-w
Abstract: The content of eight different cytokines, cell-free DNA (cfDNA) and cell-free fetal DNA (cffDNA) in women’s plasma during preterm birth (PB) was studied. The purpose of this study was to identify the relationships between the…
read more here.
Keywords:
dna;
cfdna;
cffdna;
preterm birth ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Reproductive Sciences"
DOI: 10.1007/s43032-021-00466-w
Abstract: Preeclampsia (PE) is a leading cause of maternal complications and is diagnosed by clinical manifestation. The aim of the study was to evaluate changes of cell-free DNA (cfDNA) and cell-free foetal DNA (cffDNA) concentration during…
read more here.
Keywords:
pregnancy;
dna;
cell free;
cffdna ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC"
DOI: 10.1016/j.jogc.2017.01.025
Abstract: OBJECTIVE Prenatal screening for trisomy 21 is a standard of care. Emerging cell-free fetal DNA (cffDNA) technologies can improve screening performance, but they are expensive. This study was conducted to propose a contingent screening model…
read more here.
Keywords:
scenario;
contingent;
first trimester;
performance ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Twin Research and Human Genetics"
DOI: 10.1017/thg.2017.23
Abstract: Massively parallel sequencing (MPS) technology has become increasingly available and has been widely used to screen for trisomies 21, 18, and 13 in singleton pregnancies. This study assessed the performance of MPS testing of cell-free…
read more here.
Keywords:
sequencing mps;
massively parallel;
cell free;
parallel sequencing ... See more keywords